InsiderTrades.com logo
Nvidia’s world of pain awaits
From Porter & Company   |   Ad
The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold $3 billion of Amazon… it’s why Nvidia’s CEO just sold $713 million... and it’s why Zuckerberg just sold $1.3 billion in Meta stock. The financial establishment doesn’t want you to know about this… but a controversial new documentary just pulled back the curtain and exposed what’s really going on. It’s called The Final Frontier.
Click play to stream The Final Frontier at no cost

ACXP Insider Trading

Insider Ownership Percentage: 29.60%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00

Acurx Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Acurx Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Acurx Pharmaceuticals Share Price & Price History

Current Price: $1.77
Price Change: ▼ Price Decrease of -0.05 (-2.75%)
As of 11/14/2024 01:00 AM ET

This chart shows the closing price history over time for ACXP up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
“Fed Proof” Your Bank Account with THESE 4 Simple Steps
From Weiss Ratings   |   Ad
Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.
Learn these 4 simple steps and protect your savings before it’s too late.

Acurx Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/27/2022Carl SailerDirectorBuy19,737$3.80$75,000.6092,815View SEC Filing Icon  
11/23/2021Carl SailerDirectorBuy5,161$4.84$24,979.24View SEC Filing Icon  
11/19/2021David P. LuciCEOBuy5,200$4.80$24,960.00View SEC Filing Icon  
11/19/2021Robert J. DeLucciaDirectorBuy5,034$4.90$24,666.60View SEC Filing Icon  
See Full Table
Financial Prophecy
From Porter & Company   |   Ad
The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold $3 billion of Amazon… it’s why Nvidia’s CEO just sold $713 million... and it’s why Zuckerberg just sold $1.3 billion in Meta stock. The financial establishment doesn’t want you to know about this… but a controversial new documentary just pulled back the curtain and exposed what’s really going on. It’s called The Final Frontier.
Including the name of the #1 company to buy.

SEC Filings (Institutional Ownership Changes) for Acurx Pharmaceuticals (NASDAQ:ACXP)

11.53% of Acurx Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at ACXP by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Acurx Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
10/15/2024Prospect Financial Services LLC295,075$0.56M0.3%+6.1%1.862%Search for SEC Filing on Google Icon
7/15/2024Prospect Financial Services LLC278,100$0.63M0.5%+1.9%1.756%Search for SEC Filing on Google Icon
4/23/2024Prospect Financial Services LLC272,850$0.67M0.6%+6.9%1.732%Search for SEC Filing on Google Icon
4/5/2024NBC Securities Inc.14,000$34K0.0%N/A0.089%Search for SEC Filing on Google Icon
2/20/2024Prospect Financial Services LLC255,150$0.98M1.0%N/A1.853%Search for SEC Filing on Google Icon
2/1/2024Sigma Planning Corp10,000$38K0.0%N/A0.073%Search for SEC Filing on Google Icon
11/15/2023Armistice Capital LLC500,000$0.75M0.0%-57.7%3.843%Search for SEC Filing on Google Icon
8/14/2023One68 Global Capital LLC13,044$35K0.2%N/A0.101%Search for SEC Filing on Google Icon
11/14/2022Armistice Capital LLC1,066,000$3.20M0.1%N/A9.224%Search for SEC Filing on Google Icon
8/12/2022Semmax Financial Advisors Inc.5,879$28K0.0%+365.5%0.057%Search for SEC Filing on Google Icon
8/1/2022Castle Wealth Management LLC13,000$49K0.0%N/A0.127%Search for SEC Filing on Google Icon
1/10/2022Patriot Financial Group Insurance Agency LLC7,000$30K0.0%+75.0%0.069%Search for SEC Filing on Google Icon
11/15/2021Tocqueville Asset Management L.P.19,100$98K0.0%+91.0%0.189%Search for SEC Filing on Google Icon
11/9/2021BlackRock Inc.6,515$33K0.0%N/A0.064%Search for SEC Filing on Google Icon
8/16/2021Tocqueville Asset Management L.P.10,000$64K0.0%N/A0.105%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Acurx Pharmaceuticals logo
Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. The company's lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that is in Phase 2b clinical trial to treat patients with clostridium difficile infections. It also develops ACX-375C, a potential oral and parenteral treatment targeting gram-positive bacteria, including methicillin-resistant staphylococcus aureus, vancomycin-resistant enterococcus, and penicillin-resistant streptococcus pneumonia. Acurx Pharmaceuticals, Inc. was incorporated in 2017 and is headquartered in Staten Island, New York.
Read More on Acurx Pharmaceuticals

Today's Range

Now: $1.77
Low: $1.73
High: $1.85

50 Day Range

MA: $1.96
Low: $1.77
High: $2.15

52 Week Range

Now: $1.77
Low: $1.52
High: $5.28

Volume

47,480 shs

Average Volume

90,250 shs

Market Capitalization

$28.76 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the major institutional investors of Acurx Pharmaceuticals?

Acurx Pharmaceuticals' top institutional investors include:
  1. Prospect Financial Services LLC — 1.86%
Learn More about top institutional investors of Acurx Pharmaceuticals stock.

Which major investors are buying Acurx Pharmaceuticals stock?

During the last quarter, ACXP stock was acquired by institutional investors including:
  1. Prospect Financial Services LLC
Nvidia’s world of pain awaits
From Porter & Company   |   Ad
The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold $3 billion of Amazon… it’s why Nvidia’s CEO just sold $713 million... and it’s why Zuckerberg just sold $1.3 billion in Meta stock. The financial establishment doesn’t want you to know about this… but a controversial new documentary just pulled back the curtain and exposed what’s really going on. It’s called The Final Frontier.
Click play to stream The Final Frontier at no cost